423 related articles for article (PubMed ID: 31702638)
21. [A case report--intrahepatic arterial infusion with CDDP and S-1 administration can elicit long-term survival for the patient with recurrenced intrahepatic cholangiocarcinoma after resection].
Tanida T; Tanemura M; Kobayashi S; Wada H; Marubashi S; Eguchi H; Takeda Y; Umeshita H; Mori M; Doki Y; Nagano H
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2729-31. PubMed ID: 21224694
[TBL] [Abstract][Full Text] [Related]
22. Association of Liver-Directed Local Therapy With Overall Survival in Adults With Metastatic Intrahepatic Cholangiocarcinoma.
Sebastian NT; Tan Y; Miller ED; Williams TM; Noonan AM; Hays JL; Abdel-Misih S; Diaz DA
JAMA Netw Open; 2019 Sep; 2(9):e1911154. PubMed ID: 31517963
[TBL] [Abstract][Full Text] [Related]
23. Local and abscopal responses in advanced intrahepatic cholangiocarcinoma with low TMB, MSS, pMMR and negative PD-L1 expression following combined therapy of SBRT with PD-1 blockade.
Liu X; Yao J; Song L; Zhang S; Huang T; Li Y
J Immunother Cancer; 2019 Aug; 7(1):204. PubMed ID: 31383016
[TBL] [Abstract][Full Text] [Related]
24. [Prophylactic portal vein stenting in a patient with local recurrence of cholangiocarcinoma without clinical symptoms of portal vein stenosis - a case report].
Suzuki T; Takayashiki T; Shimizu H; Ohtsuka M; Kato A; Yoshitomi H; Furukawa K; Takano S; Kuboki S; Okamura D; Suzuki D; Sakai N; Kagawa S; Miyazaki M
Gan To Kagaku Ryoho; 2014 Nov; 41(12):1536-8. PubMed ID: 25731244
[TBL] [Abstract][Full Text] [Related]
25. Significant Response to Camrelizumab Plus Targeted Drugs in Recurrent Intrahepatic Cholangiocarcinoma: a Case Report and Literature Review.
Huang P; Zhou Y; Chen Y
J Gastrointest Cancer; 2022 Sep; 53(3):817-824. PubMed ID: 34312770
[TBL] [Abstract][Full Text] [Related]
26. [Two Cases of Elderly Patients with Giant Intrahepatic Cholangiocarcinoma Treated with Multidisciplinary Therapy including Ablation Therapy].
Yamagata M; Nakajima T; Aihara T; Nishijima N; Tomoo Y; Matsuki G; Fujikawa M; Ichise N; Kasai M; Okamoto R; Ikuta S; Nakamoto Y; Osaki Y; Yanagi H; Yamanaka N
Gan To Kagaku Ryoho; 2022 Dec; 49(13):1559-1561. PubMed ID: 36733134
[TBL] [Abstract][Full Text] [Related]
27. PD-1 Inhibitors Plus Capecitabine as Maintenance Therapy for Advanced Intrahepatic Cholangiocarcinoma: A Case Report and Review of Literature.
Wang Z; Zeng T; Li Y; Zhang D; Yuan Z; Huang M; Yang Y; Zhou W
Front Immunol; 2021; 12():799822. PubMed ID: 35003124
[TBL] [Abstract][Full Text] [Related]
28. Effective Response of Intrahepatic Cholangiocarcinoma to Pembrolizumab: A Case Report.
Nakamura M; Ueno M; Hayami S; Kawai M; Miyamoto A; Suzaki N; Hirono S; Okada KI; Miyazawa M; Kitahata Y; Kobayashi R; Kojima F; Yamaue H
Anticancer Res; 2020 Jul; 40(7):4123-4129. PubMed ID: 32620661
[TBL] [Abstract][Full Text] [Related]
29. Real-world outcomes of chemotherapy plus immune checkpoint inhibitors versus chemotherapy alone in advanced, unresectable, and recurrent intrahepatic cholangiocarcinoma.
Madzikatire TB; Heng S; Gu H; Shan Y; Lin E; Banda J; Debora A; Madziva BA; Bowa MJ; Mudhuri MG; Bwalya C
Front Immunol; 2024; 15():1390887. PubMed ID: 38846939
[TBL] [Abstract][Full Text] [Related]
30. Unexpected response to systemic chemotherapy in case of primarily nonresectable advanced disseminated intrahepatic cholangiocarcinoma.
Slupski MW; Szczylik C; Jasinski MK
World J Surg Oncol; 2007 Mar; 5():36. PubMed ID: 17376238
[TBL] [Abstract][Full Text] [Related]
31. [Six-year survival with recurrent intrahepatic cholangiocarcinoma achieved by simple S-1 administration].
Miki A; Hirose T; Minami T; Morioka H; Suzuki T; Otani T; Kitamura K; Yoshitani S; Ishikawa Y; Nishihira T
Gan To Kagaku Ryoho; 2015 May; 42(5):625-8. PubMed ID: 25981660
[TBL] [Abstract][Full Text] [Related]
32. Combination of TACE and Lenvatinib as a promising option for downstaging to surgery of initially unresectable intrahepatic cholangiocarcinoma.
Yuan P; Song J; Wang F; Zhu G; Chen B
Invest New Drugs; 2022 Oct; 40(5):1125-1132. PubMed ID: 35793038
[TBL] [Abstract][Full Text] [Related]
33. Radiofrequency ablation of recurrent cholangiocarcinoma.
Slakey DP
Am Surg; 2002 Apr; 68(4):395-7. PubMed ID: 11952256
[TBL] [Abstract][Full Text] [Related]
34. [Cholangiocellular cancer: the state of the problem and ways to improve the results of surgical treatment].
Patyutko YI; Polyakov AN; Podluzhnyi DV; Syskova AY; Sagaidak IV; Kotel'nikov AG; Sergeeva ON; Pokataev IA
Khirurgiia (Mosk); 2018; (12):30-37. PubMed ID: 30560842
[TBL] [Abstract][Full Text] [Related]
35. Long-term survival after extended surgical resection of intrahepatic cholangiocarcinoma with extensive lymph node metastasis.
Asakura H; Ohtsuka M; Ito H; Kimura F; Ambiru S; Shimizu H; Togawa A; Yoshidome H; Kato A; Miyazaki M
Hepatogastroenterology; 2005; 52(63):722-4. PubMed ID: 15966191
[TBL] [Abstract][Full Text] [Related]
36. Efficacy, safety, and prognostic factors of PD-1 inhibitors combined with lenvatinib and Gemox chemotherapy as first-line treatment in advanced intrahepatic cholangiocarcinoma: a multicenter real-world study.
Zhu C; Li H; Yang X; Wang S; Wang Y; Zhang N; Wang Y; Xue J; Zhang L; Ning C; Yang X; Xun Z; Chao J; Long J; Sang X; Zhu Z; Zhao H
Cancer Immunol Immunother; 2023 Sep; 72(9):2949-2960. PubMed ID: 37247023
[TBL] [Abstract][Full Text] [Related]
37. Comparison of resection and transarterial chemoembolisation in the treatment of advanced intrahepatic cholangiocarcinoma--a single-center experience.
Scheuermann U; Kaths JM; Heise M; Pitton MB; Weinmann A; Hoppe-Lotichius M; Otto G
Eur J Surg Oncol; 2013 Jun; 39(6):593-600. PubMed ID: 23611755
[TBL] [Abstract][Full Text] [Related]
38. [Portal vein stenting as a bridge to chemotherapy for perihilar cancer with portal vein stenosis - a case report].
Tsukamoto T; Kanazawa A; Shimizu S; Sakae M; Kurihara S; Tashima T; Deguchi S; Goto W; Kotsuka M; Ishikawa A; Yoshii M; Nakajima T; Mori Y; Ohira G; Tachimori A; Tamamori Y; Yamamoto A; Inoue T; Yamashita Y; Nishiguchi Y
Gan To Kagaku Ryoho; 2014 Nov; 41(12):1539-41. PubMed ID: 25731245
[TBL] [Abstract][Full Text] [Related]
39. A case of toxic epidermal necrolysis associated with lenvatinib and sintilimab therapy for intrahepatic cholangiocarcinoma.
Gong Y; Mao J; Liu M; Gao J
J Int Med Res; 2023 May; 51(5):3000605231173556. PubMed ID: 37211771
[TBL] [Abstract][Full Text] [Related]
40. [Radiofrequency ablation of recurrent intrahepatic cholangiocarcinoma: a case report].
Genov I; Grigorov N; Mitova R; Golemanov B; Dinkov L
Khirurgiia (Sofiia); 2005; (4-5):45-7. PubMed ID: 18693517
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
